LexDanaLexDanabeta
Inventor

Shenshuang Jin

Inventor
Jiangsu, CN

Overview

2→
Patents
2019–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07DHeterocyclic compounds29%
C07BGeneral methods of organic chemistry14%
PatentTitleYear
10,759,797Pharmaceutically acceptable salt of EGFR inhibitor, crystal form thereof, preparation method therefor and application thereof202010,377,7472-arylamino pyridine, pyrimidine or triazine derivatives, preparation method and use thereof2019

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2019–2020Patents assigned to WUXI SHUANGLIANG BIOTECHNOLOGY CO LTD (2)· patent assignee history
2019Based in Wuxi, CN· patent location history
2020Based in Jiangsu, CN· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
WUXI SHUANGLIANG BIOTECHNOLOGY CO LTD22019–2020
Locations
LocationPatentsSpan
Jiangsu, CN12020
Wuxi, CN12019